Solventum US LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With A Reference Product

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-05-16
Last Posted Date
2024-12-02
Lead Sponsor
Solventum US LLC
Target Recruit Count
46
Registration Number
NCT03155204
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

3M Health Care, Loughborough, United Kingdom

Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2017-02-17
Last Posted Date
2024-12-02
Lead Sponsor
Solventum US LLC
Target Recruit Count
1
Registration Number
NCT03057132
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Eastern Regional Medical Center, Inc., Philadelphia, Pennsylvania, United States

Clinical Performance of Incremental and Bulk Fill Composites in Class II Restorations

First Posted Date
2016-09-07
Last Posted Date
2024-09-30
Lead Sponsor
Solventum US LLC
Target Recruit Count
53
Registration Number
NCT02889835
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Alabama at Birmingham Dental School, Birmingham, Alabama, United States

Cost Evaluation of Venous Leg Ulcers Management

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-04-06
Last Posted Date
2024-12-02
Lead Sponsor
Solventum US LLC
Target Recruit Count
176
Registration Number
NCT02728986
Locations
๐Ÿ‡ซ๐Ÿ‡ท

Quimper Center, Quimper, France

Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2016-04-01
Last Posted Date
2024-10-24
Lead Sponsor
Solventum US LLC
Target Recruit Count
247
Registration Number
NCT02725788
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Nebraska Medical Center, Omaha, Nebraska, United States

๐Ÿ‡บ๐Ÿ‡ธ

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

MetroHealth Medical Center, Cleveland, Ohio, United States

and more 2 locations

A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermatitis (IAD)

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-03-31
Last Posted Date
2024-12-17
Lead Sponsor
Solventum US LLC
Target Recruit Count
16
Registration Number
NCT02724449

Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products

Phase 1
Completed
Conditions
Interventions
First Posted Date
2016-02-08
Last Posted Date
2024-12-02
Lead Sponsor
Solventum US LLC
Target Recruit Count
26
Registration Number
NCT02676297
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Quotient Clinical Ltd, Ruddington, Nottingham, United Kingdom

Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-12-11
Last Posted Date
2024-12-02
Lead Sponsor
Solventum US LLC
Target Recruit Count
31
Registration Number
NCT02627625
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Quotient Clinical Ltd, Ruddington, Nottingham, United Kingdom

Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing

First Posted Date
2015-10-07
Last Posted Date
2024-10-02
Lead Sponsor
Solventum US LLC
Target Recruit Count
45
Registration Number
NCT02570139
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Good Samaritan, Kearney, Nebraska, United States

๐Ÿ‡บ๐Ÿ‡ธ

Lennox Hill, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

St. John, Tulsa, Oklahoma, United States

and more 7 locations

In Vivo Patient Preoperative Skin Prep Persistence

First Posted Date
2015-05-19
Last Posted Date
2024-10-02
Lead Sponsor
Solventum US LLC
Target Recruit Count
27
Registration Number
NCT02447497
Locations
๐Ÿ‡บ๐Ÿ‡ธ

MicroBioTest, Sterling, Virginia, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath